PDE4A and Alzheimer disease: A topical PDE-4 inhibitor such as 2% crisaborole ointment is an FDA-approved non-steroidal and anti-inflammatory treatment for mild-to-moderate AD treatment that is strongly recommended by the AAD with high certainty of evidence [45].